Andrew W. Stoker

Great Ormond Street Institute Of Child Health, 30 Guilford Street
London, ENG WC1N1EH, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

HMMR has oncoprotein-like properties in neuroblastoma cells and high HMMR expression has independent prognostic potential in neuroblastomas.

HMMR has oncoprotein-like properties in neuroblastoma cells and high HMMR expression has independent prognostic potential in neuroblastomas.

Journal: Scientific reports

Published: November 17, 2024

The cytotoxic action of BCI is not dependent on its stated DUSP1 or DUSP6 targets in neuroblastoma cells.

The cytotoxic action of BCI is not dependent on its stated DUSP1 or DUSP6 targets in neuroblastoma cells.

Journal: FEBS open bio

Published: December 21, 2021

Integrin-Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor-Specific Delivery Achieve MYCN Silencing with Improved Survival.

Integrin-Targeted, Short Interfering RNA Nanocomplexes for Neuroblastoma Tumor-Specific Delivery Achieve MYCN Silencing with Improved Survival.

Journal: Advanced functional materials

Published: May 21, 2021

A Review of DUSP26: Structure, Regulation and Relevance in Human Disease.

A Review of DUSP26: Structure, Regulation and Relevance in Human Disease.

Journal: International journal of molecular sciences

Published: December 10, 2020

MYCN Silencing by RNAi Induces Neurogenesis and Suppresses Proliferation in Models of Neuroblastoma with Resistance to Retinoic Acid.

MYCN Silencing by RNAi Induces Neurogenesis and Suppresses Proliferation in Models of Neuroblastoma with Resistance to Retinoic Acid.

Journal: Nucleic acid therapeutics

Published: April 03, 2020

The liposomal delivery of hydrophobic oxidovanadium complexes imparts highly effective cytotoxicity and differentiating capacity in neuroblastoma tumour cells.

The liposomal delivery of hydrophobic oxidovanadium complexes imparts highly effective cytotoxicity and differentiating capacity in neuroblastoma tumour cells.

Journal: Scientific reports

Published: March 12, 2020

Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells.

Liposomal delivery of hydrophobic RAMBAs provides good bioavailability and significant enhancement of retinoic acid signalling in neuroblastoma tumour cells.

Journal: Journal of drug targeting

Published: January 07, 2020

An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis.

An FDA-Approved Drug Screen for Compounds Influencing Craniofacial Skeletal Development and Craniosynostosis.

Journal: Molecular syndromology

Published: April 13, 2019

Vanadium Compounds as PTP Inhibitors.

Vanadium Compounds as PTP Inhibitors.

Journal: Molecules (Basel, Switzerland)

Published: November 30, 2017

Detection and Identification of Ligands for Mammalian RPTP Extracellular Domains.

Detection and Identification of Ligands for Mammalian RPTP Extracellular Domains.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: August 13, 2016

RPTPs in axons, synapses and neurology.

RPTPs in axons, synapses and neurology.

Journal: Seminars in cell & developmental biology

Published: July 31, 2014

Oxovanadium-based inhibitors can drive redox-sensitive cytotoxicity in neuroblastoma cells and synergise strongly with buthionine sulfoximine.

Oxovanadium-based inhibitors can drive redox-sensitive cytotoxicity in neuroblastoma cells and synergise strongly with buthionine sulfoximine.

Journal: Cancer letters

Published: July 02, 2014

Showing 1-12 of 17

Last Updated: 09/26/2026